{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T05:23:20Z","timestamp":1790573000594,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873565"],"award-info":[{"award-number":["81873565"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170593"],"award-info":[{"award-number":["82170593"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2700802"],"award-info":[{"award-number":["2021YFC2700802"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hepatobiliary & Pancreatic Diseases International"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.hbpd.2022.05.007","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T13:53:48Z","timestamp":1652795628000},"page":"511-513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["From NAFLD to MAFLD: Not just a change in the name"],"prefix":"10.1016","volume":"21","author":[{"given":"Jing","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Gao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hbpd.2022.05.007_bib0001","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1055\/s-0028-1108549","article-title":"Relationships between diabetes mellitus and fatty liver","volume":"95","author":"Beringer","year":"1970","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.hbpd.2022.05.007_bib0002","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","article-title":"Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease","volume":"55","author":"Ludwig","year":"1980","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.hbpd.2022.05.007_bib0003","first-page":"283","article-title":"Nonalcoholic fatty liver disease","volume":"8","author":"Schaffner","year":"1986","journal-title":"Prog Liver Dis"},{"key":"10.1016\/j.hbpd.2022.05.007_bib0004","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0002-9343(99)00271-5","article-title":"Association of nonalcoholic fatty liver disease with insulin resistance","volume":"107","author":"Marchesini","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.hbpd.2022.05.007_bib0005","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2022.05.007_bib0006","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/hep.31173","article-title":"Changes in the global burden of chronic liver diseases from 2012 to 2017: the growing impact of NAFLD","volume":"72","author":"Paik","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2022.05.007_bib0007","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","article-title":"New trends on obesity and NAFLD in Asia","volume":"67","author":"Fan","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2022.05.007_bib0008","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S2468-1253(20)30090-X","article-title":"Non-alcoholic fatty liver disease in non-obese individuals: the impact of metabolic health","volume":"5","author":"Eslam","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2022.05.007_bib0009","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/1751-2980.12871","article-title":"Epidemiology of nonalcoholic fatty liver disease in non-obese populations: meta-analytic assessment of its prevalence, genetic, metabolic, and histological profiles","volume":"21","author":"Zou","year":"2020","journal-title":"J Dig Dis"},{"key":"10.1016\/j.hbpd.2022.05.007_bib0010","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"International Consensus Panel. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hbpd.2022.05.007_bib0011","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2022.05.007_bib0012","doi-asserted-by":"crossref","DOI":"10.1097\/MOG.0000000000000823","article-title":"Metabolic dysfunction-associated fatty liver disease: a year in review","author":"Alharthi","year":"2022","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.hbpd.2022.05.007_bib0013","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41575-020-0316-6","article-title":"From NAFLD to MAFLD: when pathophysiology succeeds","volume":"17","author":"Tilg","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2022.05.007_bib0014","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3350\/cmh.2021.0067","article-title":"From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?","volume":"27","author":"Kang","year":"2021","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.hbpd.2022.05.007_bib0015","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.hbpd.2021.06.002","article-title":"The pathologic relevance of metabolic criteria in patients with biopsy-proven nonalcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease: a multicenter cross-sectional study in China","volume":"20","author":"Yang","year":"2021","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2022.05.007_bib0016","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.hbpd.2022.01.006","article-title":"Prevalence and characteristics of MAFLD in Chinese adults aged 40 years or older: a community-based study","volume":"21","author":"Zeng","year":"2022","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2022.05.007_bib0017","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.hbpd.2022.01.008","article-title":"NAFLD or MAFLD: that is the conundrum","volume":"21","author":"Tarantino","year":"2022","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2022.05.007_bib0018","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.cgh.2020.10.046","article-title":"Impact of the new definition of metabolic associated fatty liver disease on the epidemiology of the disease","volume":"19","author":"Wong","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2022.05.007_bib0019","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1111\/liv.14675","article-title":"MAFLD identifies patients with significant hepatic fibrosis better than NAFLD","volume":"40","author":"Yamamura","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.hbpd.2022.05.007_bib0020","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/j.cgh.2020.12.022","article-title":"Metabolic dysfunction-associated fatty liver disease and incident cardiovascular disease risk: a nationwide cohort study","volume":"19","author":"Lee","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2022.05.007_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245762","article-title":"Outcomes of NAFLD and MAFLD: results from a community-based, prospective cohort study","volume":"16","author":"Niriella","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.hbpd.2022.05.007_bib0022","doi-asserted-by":"crossref","first-page":"451","DOI":"10.5009\/gnl20218","article-title":"Clinical and histologic features of patients with biopsy-proven metabolic dysfunction-associated fatty liver disease","volume":"15","author":"Huang","year":"2021","journal-title":"Gut Liver"},{"key":"10.1016\/j.hbpd.2022.05.007_bib0023","doi-asserted-by":"crossref","first-page":"867","DOI":"10.14309\/ajg.0000000000000588","article-title":"Positive hepatitis B core antibody is associated with cirrhosis and hepatocellular carcinoma in nonalcoholic fatty liver disease","volume":"115","author":"Chan","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.hbpd.2022.05.007_bib0024","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jhep.2020.07.008","article-title":"Letter regarding \"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement\"","volume":"73","author":"Mak","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2022.05.007_bib0025","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.hbpd.2021.06.009","article-title":"Influence of weight management on the prognosis of steatohepatitis in chronic hepatitis B patients during antiviral treatment","volume":"20","author":"Chang","year":"2021","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2022.05.007_bib0026","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.31014","article-title":"Effect of metabolic traits on the risk of cirrhosis and hepatocellular cancer in nonalcoholic fatty liver disease","volume":"71","author":"Kanwal","year":"2020","journal-title":"Hepatology"}],"container-title":["Hepatobiliary & Pancreatic Diseases International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387222001254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387222001254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:42:24Z","timestamp":1761493344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499387222001254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1499387222001254"],"URL":"https:\/\/doi.org\/10.1016\/j.hbpd.2022.05.007","relation":{},"ISSN":["1499-3872"],"issn-type":[{"value":"1499-3872","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From NAFLD to MAFLD: Not just a change in the name","name":"articletitle","label":"Article Title"},{"value":"Hepatobiliary & Pancreatic Diseases International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hbpd.2022.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}